Alpha Cognition (ACOG) vs NovaBridge Biosciences (NBP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 18, 2026.
Summary
Alpha Cognition (ACOG) has outperformed NovaBridge Biosciences (NBP) over the past year, gaining 20.4% versus a loss of 78.2%. Alpha Cognition is the larger company by market cap ($178.4 million vs $146.2 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACOG | NBP |
|---|---|---|
| Share price | $8.19 | $1.26 |
| Market cap | $178.36M | $146.16M |
| 1-day change | -3.08% | -2.33% |
| YTD return | +26.00% | -68.34% |
| 1-year return | +20.44% | -78.16% |
| 5-year return | — | -98.13% |
| EPS (TTM) | $-1.32 | $-0.69 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $10.22M | — |
| Net income (latest FY) | $-20.67M | $-46.27M |
| Gross margin | 94.10% | — |
| Operating margin | -221.72% | — |
| Net margin | -202.24% | — |
| 52-week high | $10.14 | $5.97 |
| 52-week low | $4.50 | $1.26 |
| Distance from 52-week high | -19.23% | -78.89% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +119.78% | +614.29% |
| Average volume | 127.06K | 390.05K |
| Shares outstanding | 21.78M | 116.00M |
| Employees | 71 | 30 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ACOG has outperformed NBP by 98.6 percentage points over the past year.
About Alpha Cognition
ACOG stock →Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease.
Healthcare · Biotechnology · 71 employees
About NovaBridge Biosciences
NBP stock →NovaBridge Biosciences, a biotechnology company, engages in the research and development of immuno-oncology agents for the treatment of cancer in the United States. The company operates through two segments, Oncology and Ophthalmology.
Healthcare · Biotechnology · 30 employees
ACOG vs NBP FAQ
Which is bigger, Alpha Cognition or NovaBridge Biosciences?
Alpha Cognition (ACOG) is larger, with a market capitalization of $178.36M compared with $146.16M for NovaBridge Biosciences (NBP).
Which stock has performed better over the past year, ACOG or NBP?
ACOG returned +20.44% over the past 12 months, compared with -78.16% for NBP (price return, excluding dividends). Past performance does not predict future results.
Are Alpha Cognition and NovaBridge Biosciences in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.